Reopening America

Pfizer COVID-19 Vaccine Candidate 90% Effective in Early Data

Great news on the vaccine front! Pfizer’s COVID-19 vaccine candidate has been shown to be 90% effective in early findings. The Pfizer vaccine is a two-shot protocol given three weeks apart. They are still waiting on more data, but could possibly apply for emergency use authorization before the end of November. Karen Weintraub, health reporter at USA Today, joins us for what to know about the latest vaccine news. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.